Partner Content Partner Content Poor Glycaemic Control and Tooth Loss Study Poor Glycaemic Control and Tooth Loss Study
Partner Content Partner Content First results of the DiabetRisk study First results of the DiabetRisk study
News Iambic prices its IPO, seeking to raise up to $160m AI-powered drug discovery company Iambic Therapeutics has announced the terms of its Nasdaq IPO, pitching at a valuation of more than $800m.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
